海森药业:艾林拟减持不超0.97%公司股份
Group 1 - The core point of the article is that Haisen Pharmaceutical (001367) announced that its director and general manager, Ai Lin, plans to reduce his holdings by up to 1.4721 million shares, accounting for 0.97% of the company's total share capital, within three months after the announcement [1] - Ai Lin currently holds 3.96% of the company's shares, and the reason for the reduction is personal financial needs [1] - The reduction price will not be lower than the company's initial public offering price [1]